Benzyl benzoate does not cause cancer based on all available evidence. No regulatory agency classifies it as a carcinogen, animal studies have not produced tumors, and it tests negative for DNA damage in standard lab assays. Whether you’ve encountered it as a scabies treatment, a fragrance ingredient, or a food additive, the compound has been reviewed repeatedly and cleared of cancer risk.
What the Cancer Testing Shows
The most direct way to evaluate whether a chemical causes cancer is through long-term animal studies and genetic damage tests. Benzyl benzoate has been through both. In chronic exposure studies using rats and mice, no tumors developed, and carcinogenicity results came back negative. At the genetic level, it was tested in the standard bacterial reverse mutation assay (commonly called the Ames test), which checks whether a substance damages DNA in ways that could trigger uncontrolled cell growth. Benzyl benzoate tested negative for mutagenicity, both with and without metabolic activation, meaning it didn’t cause DNA mutations even when processed by enzymes that sometimes convert harmless chemicals into harmful ones.
The European Chemicals Agency, which maintains one of the most comprehensive chemical hazard databases in the world, does not classify benzyl benzoate as a carcinogen. Its official hazard statements list only acute oral toxicity at high doses and environmental toxicity to aquatic life. No cancer-related hazard codes appear. Similarly, the Joint FAO/WHO Expert Committee on Food Additives reviewed the full body of evidence and concluded that the data were “sufficient to demonstrate lack of carcinogenic potential.”
How Your Body Breaks It Down
Part of the reason benzyl benzoate poses so little cancer risk is that the body dismantles it quickly. Once absorbed, enzymes in the liver split benzyl benzoate into two simple fragments: benzyl alcohol and benzoic acid. This happens fast. In human plasma at body temperature, the half-life of benzyl benzoate is about 19 minutes, meaning half of it is already broken down in less than 20 minutes after entering the bloodstream.
Both breakdown products follow the same path. Benzyl alcohol gets oxidized into benzoic acid, which is a substance that already exists naturally in your body and in many common foods like cranberries and cinnamon. The benzoic acid then pairs with the amino acid glycine and is excreted in urine as hippuric acid. In a human study where volunteers took a 1-gram oral dose of benzyl benzoate, 85% was recovered as hippuric acid in urine. None of the metabolites along this pathway are known carcinogens.
Safety Reviews for Cosmetics and Medicine
Benzyl benzoate appears in a wide range of products, from perfumes to prescription lotions, and each use has been evaluated independently. The Cosmetic Ingredient Review Expert Panel, which assesses safety for the personal care industry, reviewed the compound and concluded that benzyl benzoate is “safe in the present practices of use and concentration.” In the EU, cosmetics must disclose benzyl benzoate on their labels if the concentration exceeds 0.001% in leave-on products, but this is an allergen disclosure requirement, not a cancer warning.
In medicine, benzyl benzoate has been used topically to treat scabies and lice for decades. The FDA has also approved a related compound, benzyl alcohol, as a prescription lotion for head lice in patients six months and older. These approvals go through toxicology reviews that would flag carcinogenic potential if it existed.
Side Effects That Do Occur
While cancer is not a concern, benzyl benzoate can cause other reactions, particularly when applied to the skin. The most common issues are local: burning, itching, redness, and skin irritation. In some people, especially those with already-inflamed skin from conditions like scabies, the irritation can worsen. Contact with eyes or mucous membranes causes more significant irritation. At very high doses (well beyond normal use), overdose symptoms can include blistering, crusting skin, difficulty urinating, and jerking movements, though these scenarios are rare and involve misuse.
Some people are allergic to benzyl benzoate as a fragrance component. The EU lists it among 26 fragrance allergens that must be declared on product labels above certain thresholds. If you’ve had contact dermatitis from perfumes or scented products, benzyl benzoate could be a contributing ingredient worth checking for on labels. But an allergic skin reaction is a fundamentally different process from cancer, involving the immune system rather than DNA damage or abnormal cell growth.